15 - 17 February, 2012, London, UK
Register by January 20 2012* and receive up to £200off!
Download the Info Pack
Access our Download Centre
Become a Pharma IQ Member and receive our weekly newsletter!
Connect to a global Pharma IQ social network
Learn more about sponsor & exhibit opportunities
Mark Your Calendar
Tell a Colleague
Laszlo Urban, Preclinical Safety ProfilingNIBR, Cambridge, Ma. presents: How To Mitigate Cardiac Toxicity During Lead Selection And Lead Optimization?
Paul Hastwell, Safety Assessment, GSK
Frank W Bonner, Stem Cell for Safer Medicines (SC4SM) presents: Exploring the Potential of Stem Cell Assays in Predictive Toxicology Testing
James A. Dykens, Investigative Toxicity Drug Safety Research & Development Sandwich, UK
Glyn Stacey, NIBSC-HPA presents: UK Stem Cell Bank: Supporting the Development of Stem Cell Models for Safety Testing.
M.B. Friedman, PhD, DABT Director of Toxicology
David R Jones, Expert Scientific Assessor (Pharmacotoxicologist), Licensing Division, Medicines and Healthcare products Regulatory Agency (MHRA), UK presents: Predictive Toxicology A Regulatory View
Vasily Dobrovolsky, Division of Genetic and Reproductive Toxicology, National Center for Toxicological Reasearch USFDA(DGRT/NCTR/FDA)
Questions? Contact us on 0800 652 2363 or +44 (0) 20 7368 9300 or email firstname.lastname@example.org now!